Cardioprotective Effects of Erythropoietin in the Reperfused Ischemic Heart
Authors:
- Jihee KimJKJihee Kim
- Ryan U. RielRRRyan U. Riel
- Laura S. PascalLPLaura S. Pascal
- Richard B. ThompsonRTRichard B. Thompson
- Jason A. PetrofskiJPJason A. Petrofski
- Akio MatsumotoAMAkio Matsumoto
- Jonathan S. StamlerJSJonathan S. Stamler
- Walter J. KochWKWalter J. Koch
Open Access
- 1 May 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (20) , 20655-20662
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- NF-κB plays a key role in hypoxia-inducible factor-1–regulated erythropoietin gene expressionExperimental Hematology, 2002
- The death-promoting activity of p53 can be inhibited by distinct signaling pathwaysBlood, 2002
- Murky waters for MRD detection in AML: flightyFLT3/ITDsBlood, 2002
- Erythropoietin Modulates Calcium Influx through TRPC2Journal of Biological Chemistry, 2002
- Role of STAT3 in Ischemic PreconditioningJournal of Molecular and Cellular Cardiology, 2001
- Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1Journal of Clinical Investigation, 2000
- Ischemia-induced STAT-1 Expression and Activation Play a Critical Role in Cardiomyocyte ApoptosisJournal of Biological Chemistry, 2000
- The Jak-STAT pathwayMolecular Immunology, 2000
- Signal Transduction in the Erythropoietin Receptor SystemExperimental Cell Research, 1999
- Cytokine receptor signallingNature, 1995